These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2146369)

  • 1. Cerebrospinal fluid acetylcholinesterase and choline measurements in Huntington's disease.
    Manyam BV; Giacobini E; Colliver JA
    J Neurol; 1990 Aug; 237(5):281-4. PubMed ID: 2146369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid acetylcholinesterase in neuropsychiatric disorders.
    Davis KL; Hollister LE; Livesey J; Berger PA
    Psychopharmacology (Berl); 1979 May; 63(2):155-9. PubMed ID: 157494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoniazid-induced alteration of CSF neurotransmitter amino acids in Huntington's disease.
    Manyam BV; Ferraro TN; Hare TA
    Brain Res; 1987 Apr; 408(1-2):125-30. PubMed ID: 2885064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid as a reflector of central cholinergic and amino acid neurotransmitter activity in cerebellar ataxia.
    Manyam BV; Giacobini E; Ferraro TN; Hare TA
    Arch Neurol; 1990 Nov; 47(11):1194-9. PubMed ID: 1978660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of isoniazid on cerebrospinal fluid and plasma GABA levels in Huntington's disease.
    Manyam NV; Hare TA; Katz L
    Life Sci; 1980 Apr; 26(16):1303-8. PubMed ID: 6446011
    [No Abstract]   [Full Text] [Related]  

  • 6. Isoniazid-induced elevation of CSF GABA levels and effects on chorea in Huntington's disease.
    Manyam BV; Katz L; Hare TA; Kaniefski K; Tremblay RD
    Ann Neurol; 1981 Jul; 10(1):35-7. PubMed ID: 6455963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choline levels are increased in cerebrospinal fluid of Alzheimer patients.
    Elble R; Giacobini E; Higgins C
    Neurobiol Aging; 1989; 10(1):45-50. PubMed ID: 2755556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cerebrospinal fluid choline levels in patients with Huntington's chorea. Negative effect of haloperidol treatment.
    Consolo S; Ladinsky H; Bianchi S; Caraceni T
    Arch Psychiatr Nervenkr (1970); 1977 May; 223(3):265-70. PubMed ID: 142461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholine and choline in cerebrospinal fluid of patients with Parkinson's disease and Huntington's chorea.
    Welch MJ; Markham CH; Jenden DJ
    J Neurol Neurosurg Psychiatry; 1976 Apr; 39(4):367-74. PubMed ID: 132512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF choline and acetylcholinesterase in early-onset vs. late-onset Alzheimer's disease patients.
    Kumar V; Giacobini E; Markwell S
    Acta Neurol Scand; 1989 Nov; 80(5):461-6. PubMed ID: 2589014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid choline levels are decreased in Parkinson's disease.
    Manyam BV; Giacobini E; Colliver JA
    Ann Neurol; 1990 Jun; 27(6):683-5. PubMed ID: 2360805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid choline, and acetylcholinesterase activity in familial vs. non-familial Alzheimer's disease patients.
    Kumar V; Giacobini E
    Arch Gerontol Geriatr; 1988 Jun; 7(2):111-7. PubMed ID: 3415394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid choline in extrapyramidal disorders.
    Aquilonius SM; Nyström B; Schuberth J; Sundwall A
    J Neurol Neurosurg Psychiatry; 1972 Oct; 35(5):720-5. PubMed ID: 4263743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems.
    Ruberg M; Villageois A; Bonnet AM; Pillon B; Rieger F; Agid Y
    J Neurol Neurosurg Psychiatry; 1987 May; 50(5):538-43. PubMed ID: 2953866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free and conjugated GABA in human cerebrospinal fluid: effect of degenerative neurologic diseases and isoniazid.
    Manyam BV; Tremblay RD
    Brain Res; 1984 Jul; 307(1-2):217-23. PubMed ID: 6235893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntington's disease. Cerebrospinal fluid GABA levels in at-risk individuals.
    Manyam NV; Hare TA; Katz L; Glaeser BS
    Arch Neurol; 1978 Nov; 35(11):728-30. PubMed ID: 152621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia.
    Nakano S; Kato T; Nakamura S; Kameyama M
    J Neurol Sci; 1986 Sep; 75(2):213-23. PubMed ID: 3760912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain amino compounds in a Huntington's disease patient on isoniazid therapy.
    Perry TL; Wall RA; Hansen S
    Neurology; 1985 May; 35(5):755-8. PubMed ID: 3157886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease.
    Ferrante RJ; Beal MF; Kowall NW; Richardson EP; Martin JB
    Brain Res; 1987 May; 411(1):162-6. PubMed ID: 2955849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CSF acetylcholinesterase activity in central neurological diseases involving cholinergic systems].
    Konagaya M; Konagaya Y; Iida M
    Rinsho Shinkeigaku; 1992 Mar; 32(3):266-71. PubMed ID: 1628449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.